4th Annual Neuropsychiatric Drug Development Summit | September 28-30, 2021 | Digital
Evvnt Promotion / evvnt
28.09.2021 - 30.09.2021 Online
Time: 8:30 am - 5:00 pm
Conference themes
This last year has been a brutal reminder as to how crucial it is that we tackle the impending global mental health crisis and find a path towards successful neuropsychiatric drug development. We are proud to be the industry’s definitive and unrivalled forum focused on encapsulating the recent clinical advances across this extremely arduous field.
This last year has been a brutal reminder as to how crucial it is that we tackle the impending global mental health crisis and find a path towards successful neuropsychiatric drug development. We are proud to be the industry’s definitive and unrivalled forum focused on encapsulating the recent clinical advances across this extremely arduous field.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
Brochure: https://go.evvnt.com/791022-3?pid=4832
Speakers: Heather Dworak Senior Director, Clinical Research Sunovion, Daniel Mathalon Professor of Psychiatry and Behavioral Sciences UCSF Weill Institute for Neurosciences and more
Brochure: https://go.evvnt.com/791022-3?pid=4832
Speakers: Heather Dworak Senior Director, Clinical Research Sunovion, Daniel Mathalon Professor of Psychiatry and Behavioral Sciences UCSF Weill Institute for Neurosciences and more
Enquiries and Registration:
https://go.evvnt.com/791022-2?pid=4832
Mr. Customer Service
General Medicine
Languages
English
English
Congress fees
Conference + 1 Workshop - Drug Developer: USD 2898.00, Conference Only - Drug Developer: USD 2399.00
Conference + 1 Workshop - Drug Developer: USD 2898.00, Conference Only - Drug Developer: USD 2399.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
